Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer’s disease
Yash Pal Singh, Gauri Shankar, Shagufta Jahan, et al.
Bioorganic & Medicinal Chemistry (2021) Vol. 46, pp. 116385-116385
Closed Access | Times Cited: 24

Showing 24 citing articles:

Design, Synthesis, and Biological Evaluation of Ferulic Acid Template-Based Novel Multifunctional Ligands Targeting NLRP3 Inflammasome for the Management of Alzheimer’s Disease
Gourav Singh, Gauri Shankar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 7, pp. 1388-1414
Closed Access | Times Cited: 5
Carbamate as a potential anti‐Alzheimer's pharmacophore: A review
Yash Pal Singh, Navneet Kumar, Brijesh Singh Chauhan, et al.
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1624-1651
Closed Access | Times Cited: 13
A recent update on huprine and its hybrids as a potential multifunctional agent for the treatment of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Design, Synthesis, and Biological Evaluation of Ferulic Acid-Piperazine Derivatives Targeting Pathological Hallmarks of Alzheimer’s Disease
Gourav Singh, Sunil Kumar, Samir Ranjan Panda, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 15, pp. 2756-2778
Closed Access | Times Cited: 3
Recent Advances in Medicinal Chemistry of Memantine Against Alzheimer's Disease
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 4
Closed Access | Times Cited: 3
Tryptamine: A privileged scaffold for the management of Alzheimer's disease
Yash Pal Singh, Harish Kumar
Drug Development Research (2023) Vol. 84, Iss. 8, pp. 1578-1594
Closed Access | Times Cited: 9
Exploration of Neuroprotective Properties of a Naturally Inspired Multifunctional Molecule (F24) against Oxidative Stress and Amyloid β Induced Neurotoxicity in Alzheimer’s Disease Models
Yash Pal Singh, Navneet Kumar, Khushbu Priya, et al.
ACS Chemical Neuroscience (2021) Vol. 13, Iss. 1, pp. 27-42
Closed Access | Times Cited: 21
Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer’s disease
Ningwei Wang, Wenlong Jia, Junqin Wang, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 107010-107010
Closed Access | Times Cited: 8
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Medicinal Chemistry Research (2022) Vol. 31, Iss. 11, pp. 1931-1947
Closed Access | Times Cited: 9
Extraction, isolation, synthesis, and biological evaluation of novel piperic acid derivatives for the treatment of Alzheimer’s disease
Jitendra Kumar, Gauri Shankar, Sunil Kumar, et al.
Molecular Diversity (2023) Vol. 28, Iss. 3, pp. 1439-1458
Closed Access | Times Cited: 4
Berberine derivatives as inhibitors of acetylcholinesterase: A systematic review
Yash Pal Singh, Harish Kumar
Chemical Biology & Drug Design (2023) Vol. 102, Iss. 6, pp. 1592-1603
Closed Access | Times Cited: 4
Repurposing the in-house generated Alzheimer’s disease targeting molecules through computational and preliminary in-vitro studies for the management of SARS-coronavirus-2
Gourav Singh, Jobin Thomas, Sahil Wadhawa, et al.
Molecular Diversity (2023) Vol. 28, Iss. 5, pp. 2847-2862
Closed Access | Times Cited: 2
Design, synthesis and evaluation of sesamol-derived acetamides as dual inhibitors of monoamine oxidases and cholinesterases
Sandeep Kumar, Rangan Mitra, Senthil Raja Ayyannan
Medicinal Chemistry Research (2024) Vol. 33, Iss. 10, pp. 1974-1991
Closed Access
Discovery of novel substituted (Z)-N'-hydroxy-3-(3-phenylureido)benzimidamide derivatives as multifunctional molecules targeting pathological hallmarks of Alzheimer’s disease
Gauri Shankar, C. Praveen Kumar, M. K. Yadav, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116959-116959
Closed Access
Multi-targeted pharmacological properties of cinnamyl piperazine derivatives: a comprehensive review
Yongqi Wang, Mengxiang Lei, Zefeng Zhao, et al.
Medicinal Chemistry Research (2024)
Closed Access
Design, synthesis and evaluation of benzothiazole-derived phenyl thioacetamides as dual inhibitors of monoamine oxidases and cholinesterases
Sandeep Kumar, Rangan Mitra, Senthil Raja Ayyannan
Molecular Diversity (2024)
Closed Access
Design, synthesis and biological evaluation of novel piperic acid and benzylpiperazine hybrid molecules for improvement of memory impairment via cholinesterase inhibitory activity
Jitendra Kumar, Gauri Shankar, Sunil Kumar, et al.
Chemical Papers (2024) Vol. 79, Iss. 1, pp. 395-415
Closed Access
Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer’s disease
Gauri Shankar, Prabhat Kumar, Sanskriti Rai, et al.
European Journal of Medicinal Chemistry (2024) Vol. 283, pp. 117066-117066
Closed Access
Phytochemistry and pharmacological advances of Ascophyllum nodosum in the management of human diseases: A comprehensive review
Brijesh Singh Chauhan, Yash Pal Singh
Phytomedicine Plus (2024), pp. 100718-100718
Open Access
Multi-Target Quinoxaline Derivatives for Alzheimer’s Disease: Inhibitory Activities Against AChE and BACE-1 Enzymes
Berkant Kurban, Derya Osmani̇ye, Begüm Nurpelin Sağlık, et al.
Polycyclic aromatic compounds (2024), pp. 1-21
Closed Access
Deoxyvasicinone hybrids in the management of Alzheimer's disease: Recent advances on manmade derivatives, pharmacological activities, and structure–activity relationship
A Gaur, Yash Pal Singh, Rajiv Sharma, et al.
Archiv der Pharmazie (2024) Vol. 358, Iss. 1
Closed Access
Synthesis of phenylethanoid glycosides from acrylic esters of glucose and aryldiazonium salts via palladium-catalyzed cross-coupling reactions and evaluation of their anti-Alzheimer activity
Aswathi C. Narayanan, Rapelly Venkatesh, Shweta Singh, et al.
Carbohydrate Research (2023) Vol. 532, pp. 108920-108920
Closed Access | Times Cited: 1
Vitamin-Based Derivatives for the Management of Alzheimer’s Disease
Tanmaykumar Varma, Pradnya Kamble, Madhavi Kumari, et al.
(2023), pp. 317-344
Closed Access
Design, Synthesis, and biological evaluation of pyrazolo-benzothiazole derivatives as a potential therapeutic agent for the treatment of Alzheimer’s disease
Harish Kumar, Anju Goyal, Navneet Kumar, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top